Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature
Upadacitinib is a Janus kinase (JAK) inhibitor approved for the treatment of different rheumatic diseases, including axial spondyloarthritis (axSpA). In phase III clinical trials, upadacitinib was associated with rapid and significant improvement in disease parameters, including scores for pain, fun...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2025-05-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/upadacitinib-for-the-treatment-of-radiographic-axial-spondyloarthritis-case-series-and-review-of-the-literature/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|